Studies have shown that active fund managers routinely underperform the S&P500 index*​

Addex Therapeutics Ltd (NASDAQ: ADXN)

ADXN Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-10.70%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE

ADXN Stock Analysis

ADXN PE Ratio:

ADXN PEG Ratio: Not Available

ADXN Forward EPS Growth (12 month): 0.00%

ADXN PS Ratio: 22.9

ADXN PSG Ratio: Not Available

ADXN Forward Revenue Growth (12 month): 0.00%

ADXN Articles

No data was found